Retatrutide 10 mg
A Triple-Agonist Metabolic Driver — A Plain-Language Guide
Retatrutide is an investigational peptide from Eli Lilly. It is a triple-agonist, meaning it activates three separate receptors at once.
Retatrutide = appetite control + insulin control + increased fat burning.
What is it?
- GLP-1 — appetite control (you naturally eat less)
- GIP — insulin response (better blood sugar management)
- Glucagon — energy burn (signals your body to release and use stored fat)
What it does
- Reduces appetite — you naturally eat less
- Improves blood sugar control
- Increases calorie burn — this is the big differentiator
- Promotes fat loss, not just weight loss
Why it's different
- Semaglutide → eat less
- Tirzepatide → eat less + better insulin
- Retatrutide → eat less + better insulin + active fat burning
The glucagon difference
The glucagon effect is what separates it — signals your body to release stored fat and can increase metabolic rate. Not just dieting — it's active fat utilization.
Clinical results
Clinical trials have shown approximately 20–24% total body weight loss — higher than Semaglutide and competitive with or better than Tirzepatide.
Why dosing is gradual
- Started low and increased slowly over weeks
- Reduces nausea and lets your body adapt
- Avoids over-suppressing appetite
What people notice
- Appetite drops quickly
- You get full faster
- Weight loss becomes easier
- Energy can feel steady (not crashy)
- Slight increase in heart rate possible (from glucagon)
Side effects (real talk)
- Nausea (most common early on)
- Appetite suppression can be strong
- Possible fatigue at first
- Mild heart rate increase — usually dose-dependent
Reconstitution
Reconstitution instructions
Add 100 units (1 mL) of bacteriostatic water to the 10 mg vial. Inject water slowly down the side of the vial. Gently swirl — do not shake. Store in refrigerator after mixing.
| Vial Size | BAC Water Added | Concentration |
|---|---|---|
| 10 mg | 100 units (1 mL) | 0.1 mg per unit |
Dosing
Dosing schedule
| Item | Instruction |
|---|---|
| Draw Amount | 10 units (0.10 mL) |
| Volume | 0.10 mL |
| Frequency | Once weekly |
| Titration | Titrate up 5–10 units if no weight loss |
| Injection Type | Subcutaneous |
Other guides
Peptide research disclaimer
This document is provided in a reference-style format for research-use-only peptide products. The preparer of this handout is not a licensed medical physician, and all information contained herein reflects personal opinion and generalized reference formatting only. Any dosing, mixing, reconstitution, or scheduling information included in this document is not medical advice, is not intended to diagnose, treat, cure, or prevent any disease, and should not be interpreted as clinical guidance.
All peptides and related compounds referenced in this document are understood to be for laboratory or research purposes only and not intended for human consumption. By using or sharing this document, the reader accepts full responsibility for any interpretation, handling, storage, reconstitution, or use of the products referenced, and the preparer disclaims liability for any misuse, unauthorized application, or consequences arising from such use.